Avatar
Forbes @forbes.com 路 Jersey City, New Jersey 馃嚡馃嚜路 4w

#AI #Biotechnology #DrugDiscovery

Link Preview
www.forbes.com
These AI Models Might Take Down Superbugs
In this week's edition of The Prototype, we look at using AI to find new drugs, quantum biotechnology, the ROI of generative AI and more.
W
The Wall Street Journal @wsj.com 路 New York City 馃嚭馃嚫路 4w

#Biotechnology #China #Innovation

Link Preview
www.wsj.com
Opinion | America Is Losing the Biotech Fight to China
The value of Chinese biotechnology companies has increased more than 100-fold over the past decade. Arthur Herman's op-ed, "America Is the Sole Superpower Again," (Jan.
Avatar
Benzinga @benzinga.com 路 Detroit 馃嚭馃嚫路 Jan 5

#Biotechnology #Epilepsy #ConferenceCall

Link Preview
www.benzinga.com
Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026 - Bright Minds Biosciences (NASDAQ:DRUG)
- Conference Call and Live Webcast at 8AM ET - NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc.
Avatar
NASDAQ Stock Market @nasdaq.com 路 New York City 馃嚭馃嚫路 Jan 5

#Biotechnology #AutoimmuneDiseases #ClinicalTrials

Link Preview
www.nasdaq.com
Jade Biosciences To Report Phase I Trial Of JADE101 In 1H2026
(RTTNews) - Jade Biosciences, Inc. (JBIO), a clinical-stage biotechnology company developing therapies for autoimmune diseases, announced its 2026 strategic priorities on Monday, including anticipated milestones before the 44th Annual J.
Avatar
Benzinga @benzinga.com 路 Detroit 馃嚭馃嚫路 Jan 5

#Biotechnology #RNAMedicines #HealthcareInnovation

Link Preview
www.benzinga.com
Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference - WAVE Life Sciences (NASDAQ:WVE)
CAMBRIDGE, Mass. , Jan. 05, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the 44th Annual J.
Avatar
Benzinga @benzinga.com 路 Detroit 馃嚭馃嚫路 Jan 5

#Biotechnology #Healthcare #InflammatoryDiseases

Link Preview
www.benzinga.com
Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference - Upstream Bio (NASDAQ:UPB)
WALTHAM, Mass. , Jan. 05, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (NASDAQ:UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Chief Executive Officer of Upstream Bio, will be presenting at the 44th Annual J.
S
StreetInsider.com @streetinsider.com 路 Jan 5

#Sustainability #SupplyChain #Biotechnology

Link Preview
www.streetinsider.com
WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement
WUXI, China, Jan. 4, 2026 /PRNewswire/ -- WuXi Biologics (2269. HK) announced it has achieved ISO 20400 Sustainable Procurement certification, an internationally recognized standard that integrates sustainability principles into procurement practices and promotes transparency and responsibility across the supply chain.